| 2025-01-31 16-13-08 | In vitro exposure of Human Umbilical Vein Endothelial Cells (HUVECs) to 4 mM Beta-Hydroxybutyrate (BHB) induces Quiescence. |
| 2025-01-31 16-10-26 | In vitro exposure of Human Umbilical Vein Endothelial Cells (HUVECs) to 4 mM Acetoacetate (AcAc) does not reduce the accumulation of Senescent Cells. |
| 2025-01-31 16-08-45 | In vitro exposure of Human Umbilical Vein Endothelial Cells (HUVECs) to 4 mM Beta-Hydroxybutyrate (BHB) reduces the accumulation of Senescent Cells. |
| 2025-01-31 16-05-19 | In vitro exposure to 4 mM Beta-Hydroxybutyrate (BHB) reduces the percentage of Human Umbilical Vein Endothelial Cells (HUVECs) in S Phase. |
| 2025-01-31 16-03-29 | In vitro exposure to 4 mM Beta-Hydroxybutyrate (BHB) increases the percentage of Human Umbilical Vein Endothelial Cells (HUVECs) in G0 Phase. |